Answers are grounded in this paper and cite their sources.
Demonstrates highly sensitive detection of pathogen DNA in clinical samples, suggesting improved biosensing methods.
Biosensing of nucleic acids by reporter proteins has the potential to outperform traditional fluorophore-based nucleic acid detection systems. However, its complexity and low sensitivity limit utility, particularly in clinical settings. Here, we devised a method that couples PCR amplification to cell-free synthesis of a HiBiT peptide, which is fragment of NanoLuc luciferase. This is achieved by tailing PCR primers with sequences required for in vitro transcription and translation of HiBiT. This method, named HiBiT-PCR, allowed us to generate NanoLuc luciferase directly from the PCR product, with a detection limit for Mycobacterium tuberculosis DNA as low as 1 copy/μL. Furthermore, we validated HiBiT-PCR using clinical samples. The results show that HiBiT-PCR is a highly sensitive and streamlined method for detecting pathogen DNA.
No takes yet. Share an insight, caveat, or question.
Muramatsu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: